Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 10 January 2019
      Blogs
 
  10 January 2019 Happy New Year from the EFPIA Legal Team

The beginning of a new year is a moment to dust off yearly strategies and to jot down the list of what needs to be done...

Read more →
 
 
 
  21 December 2018 Making the Most of Health Data to Deliver Pharmaceutical Innovation: What Are the Legal Barriers?...

A guest blog by Amanda Cole, OHE

Read more →
 
 
 
      Events
 
 
15 JAN 2019
  Symposium: Accessibility and Impact of High Value Medicines - Science, Patients &... London

A unique forum where advanced scientists, health authorities, patient advocates & industry decision-makers confront...

Learn more →
 
 
 
28 JAN 2019
  The 3rd annual Patients as Partners Europe London

The only conference in Europe that demonstrates how to involve patients throughout the entire medicines development...

Learn more →
 
 
 
12 FEB 2019
  22102018 Data Transparency Conference Brussels

Demystifying Clinical Data Transparency: Lessons learnt so far

Learn more →
 
 
 
14 FEB 2019
  7th ACCELERATE Paediatric Oncology Conference Steigenberger Wiltcher’s, Avenue Louise 71, Brussels, Belgium

An international platform of all diverse stakeholders caring about accelerating new oncology drug development for children...

Learn more →
 
 
      What we are reading
Data saves lives 06 December 2018  (Intel) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe